Alarming Low RSV Vaccine Uptake Among Older Adults Highlights Critical Public Health Gaps

Alarming Low RSV Vaccine Uptake Among Older Adults Highlights Critical Public Health Gaps

Pharm'Up

Respiratory Syncytial Virus (RSV) poses a significant and often underestimated threat to older adults, with recent data...

The Perilous Shift How the 340B Rebate Pilot Threatens Community Pharmacy Sustainability and Patient Access

Pharm'Up

The 340B Drug Pricing Program, designed to help Covered Entities (CEs)—safety-net providers like Federally Qualified Health Centers...

FDA Greenlights Zoryve Cream 0.05% as a Steroid-Free Option for Young Children with Eczema

Pharm'Up

The Food and Drug Administration (FDA) has granted a supplemental new drug application (sNDA) approval for roflumilast...

A Breath of Fresh Air Sotatercept Significantly Reduces Pulmonary Arterial Hypertension Progression in Early Diagnosis

Pharm'Up

Pulmonary arterial hypertension (PAH) is a devastating, rare, and progressive cardiovascular disorder characterized by the constriction of...

The Pharmacist as Regulator Translating FDA’s New Direct-to-Consumer Drug Ad Rules for Patients

Pharm'Up

The Food and Drug Administration (FDA) is tightening its standards for direct-to-consumer pharmaceutical advertising (DTCA), a move...

Navigating the Future of Pharmacy Essential Strategies for Student Pharmacists to Use AI Responsibly

Pharm'Up

The rapid evolution of the healthcare landscape makes the integration of artificial intelligence (AI) tools into pharmacy...

FDA Expands Approval of Evinacumab-dgnb (Evkeeza) for Homozygous Familial Hypercholesterolemia in Children as Young as One

Pharm'Up

The US Food and Drug Administration (FDA) has granted an expanded indication for evinacumab-dgnb (Evkeeza), a fully...

Amneal Submits BLA for Biosimilar to XOLAIR (Omalizumab)

Pharm'Up

Amneal Pharmaceuticals, Inc. has announced the submission of a Biologics License Application (BLA) to the U.S. Food...

Landmark Agreement: Pfizer Cuts U.S. Drug Prices Up to 85% After Pact with Trump Administration

Pharm'Up

Pfizer has signed a confidential agreement with the Trump Administration aimed at significantly lowering the cost of...

Lupin Launches Generic Rivaroxaban for Oral Suspension in the U.S. Untitled

Lupin Launches Generic Rivaroxaban for Oral Suspension in the U.S.

Pharm'Up

Lupin has announced the launch of its generic Rivaroxaban for Oral Suspension, 1 mg/mL, in the United...

Month: October 2025